Morgan Stanley Discount Zert ABT .../ DE000ME939A0 /
2024-06-03 2:56:48 PM | Chg.+0.53 | Bid7:27:21 PM | Ask7:27:21 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
91.60EUR | +0.58% | 92.03 Bid Size: 5,000 |
92.04 Ask Size: 5,000 |
Abbott Laboratories | - USD | 2025-06-27 | Call |
GlobeNewswire
05-09
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
03-25
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
03-15
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
2023-11-14
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
2023-10-19
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer
GlobeNewswire
2023-10-10
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO
GlobeNewswire
2023-10-02
Apnimed Adds Independent Director Paul Fonteyne, MS, MBA to Board of Directors
GlobeNewswire
2023-09-06
Endexx Corporation Appoints Ahmed Itani to Director of Marketing of HYLA in The Middle East Region